Detalhe da pesquisa
1.
A yeast-based system to study SARS-CoV-2 Mpro structure and to identify nirmatrelvir resistant mutations.
PLoS Pathog
; 19(8): e1011592, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37651467
2.
SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, USA, October 2020-March 2021.
Emerg Infect Dis
; 28(3): 556-563, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35081021
3.
Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition.
Nat Commun
; 15(1): 3483, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38664416
4.
A yeast-based system to study SARS-CoV-2 Mpro structure and to identify nirmatrelvir resistant mutations.
Res Sq
; 2022 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36052369
5.
Discovery of Dual TAF1-ATR Inhibitors and Ligand-Induced Structural Changes of the TAF1 Tandem Bromodomain.
J Med Chem
; 65(5): 4182-4200, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35191694
6.
A yeast-based system to study SARS-CoV-2 M pro structure and to identify nirmatrelvir resistant mutations.
bioRxiv
; 2022 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35982672
7.
EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma.
Cancer Discov
; 12(3): 730-751, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34772733
8.
Differential BET Bromodomain Inhibition by Dihydropteridinone and Pyrimidodiazepinone Kinase Inhibitors.
J Med Chem
; 64(21): 15772-15786, 2021 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34710325
9.
Development of Dimethylisoxazole-Attached Imidazo[1,2-a]pyridines as Potent and Selective CBP/P300 Inhibitors.
J Med Chem
; 64(9): 5787-5801, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33872011